-
1
-
-
33745665232
-
-
Stewart B.W., and Kleihues P. (Eds), IARC Press, Lyon, France
-
In: Stewart B.W., and Kleihues P. (Eds). WHO world cancer report (2003), IARC Press, Lyon, France
-
(2003)
WHO world cancer report
-
-
-
3
-
-
33947184242
-
Alternate molecular genetic pathways in ovarian carcinomas of common histological types
-
Willner J., Wurz K., Allison K.H., et al. Alternate molecular genetic pathways in ovarian carcinomas of common histological types. Hum Pathol 38 (2007) 607-613
-
(2007)
Hum Pathol
, vol.38
, pp. 607-613
-
-
Willner, J.1
Wurz, K.2
Allison, K.H.3
-
4
-
-
41349101947
-
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis
-
Kurman R.J., Visvanathan K., Roden R., et al. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 198 (2008) 351-356
-
(2008)
Am J Obstet Gynecol
, vol.198
, pp. 351-356
-
-
Kurman, R.J.1
Visvanathan, K.2
Roden, R.3
-
5
-
-
41349105997
-
Histologic subtypes of ovarian carcinoma: an overview
-
Soslow R.A. Histologic subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol 27 (2008) 161-174
-
(2008)
Int J Gynecol Pathol
, vol.27
, pp. 161-174
-
-
Soslow, R.A.1
-
6
-
-
43049099384
-
Genomic analysis of epithelial ovarian cancer
-
Farley J., Ozbun L.L., and Birrer M.J. Genomic analysis of epithelial ovarian cancer. Cell Res 18 (2008) 538-548
-
(2008)
Cell Res
, vol.18
, pp. 538-548
-
-
Farley, J.1
Ozbun, L.L.2
Birrer, M.J.3
-
7
-
-
41349100528
-
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications
-
Kurman R.J., and Shih Ie M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27 (2008) 151-160
-
(2008)
Int J Gynecol Pathol
, vol.27
, pp. 151-160
-
-
Kurman, R.J.1
Shih Ie, M.2
-
8
-
-
36448949851
-
Etiology and pathogenesis of epithelial ovarian cancer
-
Mok S.C., Kwong J., Welch W.R., et al. Etiology and pathogenesis of epithelial ovarian cancer. Dis Markers 23 (2007) 367-376
-
(2007)
Dis Markers
, vol.23
, pp. 367-376
-
-
Mok, S.C.1
Kwong, J.2
Welch, W.R.3
-
9
-
-
39749171410
-
Early events in the pathogenesis of epithelial ovarian cancer
-
Landen Jr. C.N., Birrer M.J., and Sood A.K. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 26 (2008) 995-1005
-
(2008)
J Clin Oncol
, vol.26
, pp. 995-1005
-
-
Landen Jr., C.N.1
Birrer, M.J.2
Sood, A.K.3
-
10
-
-
0035421991
-
Genetic analysis of early-versus late-stage ovarian tumors
-
Shridhar V., Lee J., Pandita A., et al. Genetic analysis of early-versus late-stage ovarian tumors. Cancer Res 61 (2001) 5895-5904
-
(2001)
Cancer Res
, vol.61
, pp. 5895-5904
-
-
Shridhar, V.1
Lee, J.2
Pandita, A.3
-
11
-
-
33745881036
-
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation
-
Finch A., Beiner M., Lubinski J., et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296 (2006) 185-192
-
(2006)
JAMA
, vol.296
, pp. 185-192
-
-
Finch, A.1
Beiner, M.2
Lubinski, J.3
-
12
-
-
33846187651
-
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
-
Lee Y., Miron A., Drapkin R., et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211 (2007) 26-35
-
(2007)
J Pathol
, vol.211
, pp. 26-35
-
-
Lee, Y.1
Miron, A.2
Drapkin, R.3
-
13
-
-
33846185401
-
The distal fallopian tube: a new model for pelvic serous carcinogenesis
-
Crum C.P., Drapkin R., Miron A., et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19 (2007) 3-9
-
(2007)
Curr Opin Obstet Gynecol
, vol.19
, pp. 3-9
-
-
Crum, C.P.1
Drapkin, R.2
Miron, A.3
-
14
-
-
33645225423
-
The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome
-
Medeiros F., Muto M.G., Lee Y., et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30 (2006) 230-236
-
(2006)
Am J Surg Pathol
, vol.30
, pp. 230-236
-
-
Medeiros, F.1
Muto, M.G.2
Lee, Y.3
-
15
-
-
55149119938
-
The relationship of endometriosis and ovarian malignancy: a review
-
Nezhat F., Datta M.S., Hanson V., et al. The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 90 (2008) 1559-1570
-
(2008)
Fertil Steril
, vol.90
, pp. 1559-1570
-
-
Nezhat, F.1
Datta, M.S.2
Hanson, V.3
-
16
-
-
0034671218
-
Loss of heterozygosity on 10q23 3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary
-
Sato N., Tsunoda H., Nishida M., et al. Loss of heterozygosity on 10q23 3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60 (2000) 7052-7056
-
(2000)
Cancer Res
, vol.60
, pp. 7052-7056
-
-
Sato, N.1
Tsunoda, H.2
Nishida, M.3
-
18
-
-
0026587992
-
Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer
-
Godwin A.K., Testa J.R., Handel L.M., et al. Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst 84 (1992) 592-601
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 592-601
-
-
Godwin, A.K.1
Testa, J.R.2
Handel, L.M.3
-
19
-
-
0028261059
-
Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity
-
Testa J.R., Getts L.A., Salazar H., et al. Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Res 54 (1994) 2778-2784
-
(1994)
Cancer Res
, vol.54
, pp. 2778-2784
-
-
Testa, J.R.1
Getts, L.A.2
Salazar, H.3
-
20
-
-
0032477328
-
Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone
-
Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90 (1998) 1774-1786
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1774-1786
-
-
Risch, H.A.1
-
21
-
-
0029816209
-
Epithelial ovarian cancer risk among women with polycystic ovary syndrome
-
Schildkraut J.M., Schwingl P.J., Bastos E., et al. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88 (1996) 554-559
-
(1996)
Obstet Gynecol
, vol.88
, pp. 554-559
-
-
Schildkraut, J.M.1
Schwingl, P.J.2
Bastos, E.3
-
22
-
-
0029930874
-
Changes in androgens during treatment with four low-dose contraceptives
-
Coenen C.M., Thomas C.M., Borm G.F., et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 53 (1996) 171-176
-
(1996)
Contraception
, vol.53
, pp. 171-176
-
-
Coenen, C.M.1
Thomas, C.M.2
Borm, G.F.3
-
23
-
-
1442327535
-
Androgens and ovarian cancers
-
Wang P.H., and Chang C. Androgens and ovarian cancers. Eur J Gynaecol Oncol 25 (2004) 157-163
-
(2004)
Eur J Gynaecol Oncol
, vol.25
, pp. 157-163
-
-
Wang, P.H.1
Chang, C.2
-
24
-
-
33645801003
-
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
-
Melin A., Sparen P., Persson I., et al. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 21 (2006) 1237-1242
-
(2006)
Hum Reprod
, vol.21
, pp. 1237-1242
-
-
Melin, A.1
Sparen, P.2
Persson, I.3
-
26
-
-
0033199807
-
Possible role of ovarian epithelial inflammation in ovarian cancer
-
Ness R.B., and Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91 (1999) 1459-1467
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1459-1467
-
-
Ness, R.B.1
Cottreau, C.2
-
27
-
-
3142717392
-
NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer
-
Altinoz M.A., and Korkmaz R. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Neoplasma 51 (2004) 239-247
-
(2004)
Neoplasma
, vol.51
, pp. 239-247
-
-
Altinoz, M.A.1
Korkmaz, R.2
-
28
-
-
0032893042
-
The role of cytokines in both the normal and malignant ovary
-
Nash M.A., Ferrandina G., Gordinier M., et al. The role of cytokines in both the normal and malignant ovary. Endocr Relat Cancer 6 (1999) 93-107
-
(1999)
Endocr Relat Cancer
, vol.6
, pp. 93-107
-
-
Nash, M.A.1
Ferrandina, G.2
Gordinier, M.3
-
29
-
-
33745102031
-
Molecular pathology of epithelial ovarian cancer
-
Christie M., and Oehler M.K. Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc (2006) 12
-
(2006)
J Br Menopause Soc
, pp. 12
-
-
Christie, M.1
Oehler, M.K.2
-
30
-
-
0032941343
-
Cancer risk in mutation carriers of DNA-mismatch-repair genes
-
Aarnio M., Sankila R., Pukkala E., et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81 (1999) 214-218
-
(1999)
Int J Cancer
, vol.81
, pp. 214-218
-
-
Aarnio, M.1
Sankila, R.2
Pukkala, E.3
-
31
-
-
0034897120
-
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer
-
Watson P., Butzow R., Lynch H.T., et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 82 (2001) 223-228
-
(2001)
Gynecol Oncol
, vol.82
, pp. 223-228
-
-
Watson, P.1
Butzow, R.2
Lynch, H.T.3
-
32
-
-
30444435538
-
Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival
-
Beeghly A., Katsaros D., Chen H., et al. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol 100 (2006) 330-337
-
(2006)
Gynecol Oncol
, vol.100
, pp. 330-337
-
-
Beeghly, A.1
Katsaros, D.2
Chen, H.3
-
33
-
-
38849190562
-
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set
-
Beesley J., Jordan S.J., Spurdle A.B., et al. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. Cancer Epidemiol Biomarkers Prev 16 (2007) 2557-2565
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 2557-2565
-
-
Beesley, J.1
Jordan, S.J.2
Spurdle, A.B.3
-
34
-
-
38549127886
-
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis
-
Pearce C.L., Wu A.H., Gayther S.A., et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. Br J Cancer 98 (2008) 282-288
-
(2008)
Br J Cancer
, vol.98
, pp. 282-288
-
-
Pearce, C.L.1
Wu, A.H.2
Gayther, S.A.3
-
35
-
-
0042624835
-
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
-
Gemignani M.L., Schlaerth A.C., Bogomolniy F., et al. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma. Gynecol Oncol 90 (2003) 378-381
-
(2003)
Gynecol Oncol
, vol.90
, pp. 378-381
-
-
Gemignani, M.L.1
Schlaerth, A.C.2
Bogomolniy, F.3
-
36
-
-
0037454224
-
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
-
Singer G., Oldt III R., Cohen Y., et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95 (2003) 484-486
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 484-486
-
-
Singer, G.1
Oldt III, R.2
Cohen, Y.3
-
37
-
-
0032054206
-
Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas
-
Palacios J., and Gamallo C. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 58 (1998) 1344-1347
-
(1998)
Cancer Res
, vol.58
, pp. 1344-1347
-
-
Palacios, J.1
Gamallo, C.2
-
39
-
-
7444250290
-
Mutation of the PIK3CA gene in ovarian and breast cancer
-
Campbell I.G., Russell S.E., Choong D.Y., et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64 (2004) 7678-7681
-
(2004)
Cancer Res
, vol.64
, pp. 7678-7681
-
-
Campbell, I.G.1
Russell, S.E.2
Choong, D.Y.3
-
40
-
-
0032523808
-
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
-
Obata K., Morland S.J., Watson R.H., et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 58 (1998) 2095-2097
-
(1998)
Cancer Res
, vol.58
, pp. 2095-2097
-
-
Obata, K.1
Morland, S.J.2
Watson, R.H.3
-
41
-
-
50249111103
-
A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer
-
Pal T., Permuth-Wey J., and Sellers T.A. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer 113 (2008) 733-742
-
(2008)
Cancer
, vol.113
, pp. 733-742
-
-
Pal, T.1
Permuth-Wey, J.2
Sellers, T.A.3
-
42
-
-
0035575740
-
Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors
-
Gras E., Catasus L., Arguelles R., et al. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 92 (2001) 2829-2836
-
(2001)
Cancer
, vol.92
, pp. 2829-2836
-
-
Gras, E.1
Catasus, L.2
Arguelles, R.3
-
43
-
-
0033541548
-
Screening for ovarian cancer: a pilot randomised controlled trial
-
Jacobs I.J., Skates S.J., MacDonald N., et al. Screening for ovarian cancer: a pilot randomised controlled trial. Lancet 353 (1999) 1207-1210
-
(1999)
Lancet
, vol.353
, pp. 1207-1210
-
-
Jacobs, I.J.1
Skates, S.J.2
MacDonald, N.3
-
44
-
-
41649110649
-
Imaging in the era of molecular oncology
-
Weissleder R., and Pittet M.J. Imaging in the era of molecular oncology. Nature 452 (2008) 580-589
-
(2008)
Nature
, vol.452
, pp. 580-589
-
-
Weissleder, R.1
Pittet, M.J.2
-
45
-
-
33744730025
-
Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review
-
Dietel M., and Sers C. Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review. Virchows Arch 448 (2006) 744-755
-
(2006)
Virchows Arch
, vol.448
, pp. 744-755
-
-
Dietel, M.1
Sers, C.2
-
46
-
-
52449084470
-
Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation
-
Varadhachary G.R., Talantov D., Raber M.N., et al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26 (2008) 4442-4448
-
(2008)
J Clin Oncol
, vol.26
, pp. 4442-4448
-
-
Varadhachary, G.R.1
Talantov, D.2
Raber, M.N.3
-
47
-
-
62849110875
-
-
Accessed 15/12/08
-
http://www.cancer.gov/clinicaltrials/GOG-0239. (Accessed 15/12/08).
-
-
-
-
48
-
-
57449092484
-
KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer
-
Nakayama N., Nakayama K., Yeasmin S., et al. KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer. Br J Cancer 99 (2008) 2020-2028
-
(2008)
Br J Cancer
, vol.99
, pp. 2020-2028
-
-
Nakayama, N.1
Nakayama, K.2
Yeasmin, S.3
-
49
-
-
56249133327
-
Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids
-
Luo H., Jiang B.H., King S.M., et al. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer 60 (2008) 800-809
-
(2008)
Nutr Cancer
, vol.60
, pp. 800-809
-
-
Luo, H.1
Jiang, B.H.2
King, S.M.3
-
50
-
-
62849099968
-
-
Accessed 15/12/08
-
http://www.cancer.gov/clinicaltrials/GOG-0170I. (Accessed 15/12/08).
-
-
-
-
51
-
-
48149110374
-
The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review)
-
Oei A.L., Sweep F.C., Thomas C.M., et al. The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review). Int J Oncol 32 (2008) 1145-1157
-
(2008)
Int J Oncol
, vol.32
, pp. 1145-1157
-
-
Oei, A.L.1
Sweep, F.C.2
Thomas, C.M.3
-
52
-
-
53149147473
-
The potential of PARP inhibitors in genetic breast and ovarian cancers
-
Drew Y., and Calvert H. The potential of PARP inhibitors in genetic breast and ovarian cancers. Ann N Y Acad Sci 1138 (2008) 136-145
-
(2008)
Ann N Y Acad Sci
, vol.1138
, pp. 136-145
-
-
Drew, Y.1
Calvert, H.2
-
53
-
-
17244375049
-
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
-
Bryant H.E., Schultz N., Thomas H.D., et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434 (2005) 913-917
-
(2005)
Nature
, vol.434
, pp. 913-917
-
-
Bryant, H.E.1
Schultz, N.2
Thomas, H.D.3
-
54
-
-
17244373777
-
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
-
Farmer H., McCabe N., Lord C.J., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434 (2005) 917-921
-
(2005)
Nature
, vol.434
, pp. 917-921
-
-
Farmer, H.1
McCabe, N.2
Lord, C.J.3
-
55
-
-
62849102310
-
-
P. C. Fong, D. S. Boss, C. P. Carden, et al. AZD2281 (KU-0059436), a PARP (poly ADP-ribose polymerase) inhibitor with single agent anticancer activity in patients with BRCA deficient ovarian cancer: Results from a phase I study. J Clin Oncol, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). 26, No 15S (May 20 Supplement), 2008: 5510.
-
P. C. Fong, D. S. Boss, C. P. Carden, et al. AZD2281 (KU-0059436), a PARP (poly ADP-ribose polymerase) inhibitor with single agent anticancer activity in patients with BRCA deficient ovarian cancer: Results from a phase I study. J Clin Oncol, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 26, No 15S (May 20 Supplement), 2008: 5510.
-
-
-
-
56
-
-
62849106997
-
-
Accessed 15/12/08
-
http://clinicaltrials.gov/ct2/show/NCT00516373. (Accessed 15/12/08).
-
-
-
-
57
-
-
62849083414
-
-
Accessed 15/12/08
-
http://clinicaltrials.gov/ct2/show/NCT00753545. (Accessed 15/12/08).
-
-
-
-
58
-
-
62849116315
-
-
Accessed 15/12/08
-
http://www.cancer.gov/clinicaltrials/CRUK-PH2/052. (Accessed 15/12/08).
-
-
-
|